Blood drawn
PreclinicalBiologic
Blood drawn is one of 82 biologic programs targeting HIV infection. It is currently in Preclinical.
2
Indications
3
Total Trials
1
Active Trials
81
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
123 competitors in HIV Infection
#DrugCompanyPhaseTrials
1Agenerase
GGlaxo Dba Glaxosmithkline
Approved
Calciferol
Jazz PharmaceuticalsApproved
Crestor
AstraZenecaApproved
Istodax
TevaApproved
Marinol
Jazz PharmaceuticalsApproved
Neoral
NovartisApproved
Tybost
GileadApproved
Ninlaro
TakedaApproved
Rifadin
SanofiApproved
Soriatane
GSKApproved
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Inflammatory Response1 trial
Colon Cancer1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Blood drawn. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Biologic[2]
- Highest Phase
- Preclinical[1]
- Company
- UUniversity Hospital, Rouen